medRxivGenetic & Genomic MedicinePreprint
Massively parallel functional profiling identifies CCDC88C as a risk gene for ER-positive breast cancer
Kate MackieiD, Harriet KempiD, Andrea GunnelliD, James B. StuddiD, Molly WentiD, Philip J. LawiD, Katarzyna TomczykiD, Selin Sevgi, Yunjiao Lu, Nick OrriD, Richard S. HoulstoniD, Nichola JohnsoniD, Olivia FletcheriD, Syed HaideriD
Abstract
Genome wide association studies (GWAS), combined with fine-mapping have identified 196 independent signals associated with breast cancer risk. Deciphering the functional basis of these associations can inform our understanding of the biology and aetiology of breast cancer. Decoding GWAS risk associations is challenging due to linkage disequilibrium between variants and because most variants map to non-coding regions, influencing breast cancer risk via cis-regulatory mechanisms that modulate the expression of target genes. To identify the functional variants driving breast cancer risk associations, we carried out a lentivirus-based massively parallel reporter assay (lentiMPRA) to screen 5,116 credible causal variants across these signals. We identified 709 variants mapping to 140 risk regions, that are associated with significant variation between REF and ALT alleles. A follow-up investigation at 14q32.11 revealed rs7153397 may impact expression of CCDC88C to influence both breast cancer risk and prognosis. These findings provide a prioritised set of functional variants for downstream analyses, advancing our understanding of breast cancer risk mechanisms.
- organism: human
- assay: GWAS summary statistics
- research focus: fine-mapping
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes
GEMO Study Collaborators, Laura Fachal, … Peter Andreas Fasching·Nature GeneticsPeer-reviewed·Jan 1, 2020
- High-throughput allelic expression imbalance analyses identify candidate breast cancer risk genes
Mahdi Moradi Marjaneh, Haran Sivakumaran, … Juliet D. French·bioRxiv·Jan 16, 2019
- Mapping of cis-regulatory variants by differential allelic expression analysis identifies candidate causal variants and target genes of 41 breast cancer risk loci
Joana M. Xavier, Ramiro Magno, … Ana-Teresa Maia·medRxiv·Mar 8, 2022
- Germline Allelic Expression of Genes at 17q22 Locus Associates with Risk of Breast Cancer
Filipa Esteves, Joana M. Xavier, … Ana-Teresa Maia·European Journal of CancerPeer-reviewed·Jun 27, 2022
- Chromatin interactome mapping at 139 independent breast cancer risk signals
Jonathan Beesley, Haran Sivakumaran, … Stacey L. Edwards·Genome biologyPeer-reviewed·Jan 7, 2020
- Estrogen interactions with breast cancer risk variants in regulatory DNA
Ibtihal Elfaki, Laura N. Kellman, … Paul A. Khavari·medRxiv·Sep 11, 2026